In-Depth Examination Of 11 Analyst Recommendations For AbbVie
In-Depth Examination Of 11 Analyst Recommendations For AbbVie
對艾伯維公司的11個分析師建議進行深入研究
The standing of AbbVie among...Analysts' ratings for AbbVie (NYSE:ABBV) over the last quarter vary from bullish to bearish, as provided by 11 analysts.
過去一季度，11位分析師對AbbVie（紐交所：ABBV）的評級從看好到看淡不一。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級概況，突出了過去30天內情緒的變化，並將其與之前的月份進行了比較。
Analysts have recently evaluated AbbVie and provided 12-month price targets. The average target is $208.09, accompanied by a high estimate of $225.00 and a low estimate of $196.00. This upward trend is evident, with the current average reflecting a 6.22% increase from the previous average price target of $195.91.
分析師最近對艾伯維公司進行了評估，並提供了12個月的價格目標。平均目標價格爲208.09美元，最高估值爲225.00美元，最低估值爲196.00美元。這種上升趨勢是顯而易見的，當前平均價格反映了與先前的平均目標價格195.91美元相比增長了6.22%。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查：一項詳盡的研究
The standing of AbbVie among...
通過對最近...
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間